This webinar will explore how Australasian essential oils can counteract the overuse of antibiotics and subsequent multi-drug resistance.
The unnecessary overuse of antibiotics and subsequent multi-drug resistance is widely recognized as a major threat to global health, progress and sustainability. The World Health Organization (WHO), as early as 2014, declared antimicrobial multi-drug resistance a global crisis. WHO continues to raise awareness that this is one of the world’s most urgent public health problems. This crisis affects all regions of the world and impacts many areas of life.
The Centers for Disease Control says antibiotic resistance has the potential to affect people at any stage of life, across a number of industries including healthcare, veterinary, and agriculture. Each year in the U.S., at least 2 million people are infected with antibiotic-resistant bacteria, and at least 23,000 people die as a result. Fighting this threat is a public health priority that requires a collaborative global approach across sectors.
This webinar will review recent research highlighting the clinical Aromatherapeutic and biological potential of unique Australasian (Australia and New Zealand) essential oils to assist in the management of this global crisis. Australasian oils offer not only unique and new synergistic constituent profiles and be used as a potential alternative to antibiotics but also when combined with antibiotics offer a new choice for treatment of antibiotic resistant bacteria. Research shows that a number of these essential oils can be active modifying agents for antibiotics. This offers not only new markets for these oils but access to a variety of industry sectors such as veterinary science which has also taken an interest in using essential oils as anthelmintic agents to combat parasites. A number of parasites have become resistant to commonly used anthelmintic pharmaceuticals.
The presentation will also review new unique applications of essential oil administration such as nanoparticle delivery providing a source of potential new products such as localized topical administration using sterile gauze dressings impregnated with essential oil nanoparticles for the treatment of skin and soft tissue infections following surgery.